Teishima, J., T. Hara, T. Tobe, J. Hirata, H. Ueki, N. Wakita, Y. Shiraishi, Y. Okamura, Y. Bando, T. Terakawa, J. Furukawa, K.- ichi Harada, Y. Nakano, and M. Fujisawa. “Therapeutic Outcome of Combination Therapy Using Immune-Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Metastatic Non-Clear-Cell Renal Cell Carcinoma”. Canadian Urological Association Journal, vol. 18, no. 5, Jan. 2024, pp. E162-6, doi:10.5489/cuaj.8548.